Save Article

Abbott to Pay $184 Million In Tricor Suits

By

Shirley S. Wang

Updated Nov. 21, 2008 12:01 a.m. ET

Abbott Laboratories said it agreed to pay $184 million to settle litigation with several pharmacies, wholesalers and generics companies over allegations that the company created a monopoly and prevented generic competition with its anticholesterol drug TriCor.

The settlement was disclosed in a filing Thursday with the Securities and Exchange Commission. Other TriCor suits filed by state attorneys general, insurance companies and consumers remain outstanding, but Thursday's action represents the bulk of the lawsuits, the company...